Burgos Munoz, Javier Santos,Adrio Fondevila, Jose Luis,Ramos Martin, Maria Del Carmen,Sierra Avila, Saleta,Alfaro Sanchez, Juan Maria,Ramirez Moreno, Carlos,Campoy Garcia, Sonia,Velasco Alvarez, Javie
申请号:
AU2010238429
公开号:
AU2010238429B2
申请日:
2010.04.16
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid form and salts thereof, etc. for use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with unwanted oxidation, pathological processes associated with age and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases, such as atherosclerosis, auricular fibrillation, dyslipemia, hypercholesterolaemia, hyperlipidaemia and hypertriglyceridemia or fungal or viral infections.